NOVOCURE LTD
NVCRNASDAQ🏆 #1668 by market capEarnings Oct 29US Equity
$17.66▲ $0.36 (+2.02%)
Market closed · at close1h—
24h▲ 2.0%
7d▲ 10.0%
14d▲ 16.3%
30d▲ 9.8%
1y▲ 55.6%
🏦Market Cap
$2.06B
Small Cap
📈Revenue Growth (YoY)
+8.3%
Slowing
📊Gross Margin
76.1%
High
💵FCF Margin
-3.0%
Thin
⚖️P/S Ratio
2.9x
Cheap
Otter Score
54
Weak
📊
Analyst Ratings
Price
$17.66
Total
15
Raised
1
Lowered
1
Avg PT
$26.00
H / L
$32 / $20
| Institution | Action | Rating | Date |
|---|---|---|---|
Wedbush | Reiterated | Neutral | 2026-07-24 |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-23 |
Wells Fargo | Reiterated | Equal Weight | 2026-05-04 |
Evercore ISI Group | Reiterated | Outperform | 2026-05-01 |
JP Morgan | Reiterated | Neutral | 2025-10-27 |
Piper Sandler | Reiterated | Overweight | 2025-06-27 |
Truist Securities | Reiterated | Buy | 2023-06-06 |
Loop Capital | Reiterated | Buy | 2022-02-08 |
Oppenheimer | Upgraded | Perform → Outperform | 2022-02-02 |
Mizuho | Reiterated | Neutral | 2021-07-30 |
Northland Capital Markets | Reiterated | Outperform | 2021-04-14 |
SunTrust Robinson Humphrey | Reiterated | Buy | 2020-05-01 |
Deutsche Bank | Downgraded | Buy → Hold | 2018-07-26 |
Barclays | Reiterated | Underweight | 2016-07-29 |
JMP Securities | Reiterated | Market Outperform | 2016-07-29 |
One row per institution, most recent rating